Definitive Healthcare
Turning healthcare data into intelligence that accelerates innovation, improves decisions, and shapes better outcomes.
Turning healthcare data into intelligence that accelerates innovation, improves decisions, and shapes better outcomes.
Published Oct 23, 2026
| Starting Price | Custom quote (not published) | Not published (enterprise sales; varies) | Not published (enterprise / project-based) |
| Typical Use Case | Healthcare commercial intelligence across providers/HCPs/claims context; GTM targeting; Salesforce-centric teams; KOL/expert workflows via Monocl | Life sciences commercialization + analytics + large-scale data + consulting (broad portfolio) | US real-world intelligence, integrated healthcare datasets, payer/transaction linkage strengths |
| Key Strength | Broad healthcare entity coverage with affiliations and workflow integrations, including Salesforce-native options | Scale and breadth of life sciences analytics, global footprint, and services | High-volume US healthcare transaction processing and linked data assets |
| Key Weakness | Quote-based pricing opacity; reported UX/search and integration reliability concerns; limited public detail on some enterprise security controls | Can be expensive/complex; services-heavy engagements may increase cost and time | Pricing opacity; may be optimized for life sciences/RWE use cases versus general commercial prospecting |
Definitive and IQVIA target different primary problems: IQVIA focuses on life sciences solutions, RWE, and services, while Definitive centers on provider/HCP entity data and GTM targeting workflows. Buyers should clarify whether the primary need is sales and market targeting intelligence versus RWE, market access, and large-scale analytics programs.
Compared with Symphony Health (ICON), Symphony emphasizes high-volume transaction processing and payer/transaction linkage, while Definitive emphasizes packaged commercial intelligence workflows and cross-entity mapping (organizations, people, affiliations, and claims context).
Compared with ZoomInfo (an adjacent alternative), ZoomInfo is not healthcare-specialized but can be simpler and lower cost for general contact discovery. ZoomInfo generally does not provide the same healthcare-specific entity resolution, affiliation modeling, or claims-derived context.
Adoption and market trends: Third-party commentary suggests budget pressure in life sciences subscriptions in recent periods and a shift toward digital engagement and activation. Treat such commentary as directional unless confirmed in audited filings.